Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-FOLR1 CAR T cells

A preparation of T lymphocytes that have been engineered to express a chimeric antigen receptor (CAR) specific for folate receptor alpha (FolRa; FOLR1), with potential immunostimulating and antineoplastic activities. Upon administration, anti-FOLR1 CAR T cells specifically recognize and bind to FOLR1-expressing tumor cells, resulting in specific T-cell-mediated tumor cell lysis. FOLR1 is a glycosylphosphatidylinositol linked cell surface glycoprotein that is widely expressed in certain cancers while its expression is limited in normal tissues.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	anti-FOLR1 CAR-T cells FH-FOLR1 CAR T cells

anti-FOLR1 CAR T cells

Search NCI's Drug Dictionary